| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 |
|---|---|---|---|---|---|---|---|---|
Cash flows provided by operating activities: | ||||||||
Net income | ||||||||
1,688 | 679 | 2,346 | 958 | 735 | 131 | 93 | -2,713 | -2,281 |
Adjustments to reconcile net income to net cash from operating activities: | ||||||||
Depreciation and amortization | ||||||||
321 | 348 | 393 | 351 | 405 | - | - | - | - |
Amortization of operating lease right-of-use assets | ||||||||
453 | - | - | - | - | - | - | - | - |
Accretion of financing instruments and amortization of prepaid financing costs | ||||||||
- | - | - | - | - | - | 235 | 13 | 905 |
Impairment charge on investment in iBio, Inc. | ||||||||
- | - | - | - | - | -152 | -139 | - | - |
Compensation expense on employee stock options | ||||||||
- | - | - | - | - | 0 | - | 10 | 255 |
Gain on common stock sales of iBio, Inc. | ||||||||
- | - | - | - | 48 | 0 | - | - | - |
Change in fair value of derivative liability | ||||||||
-9 | -494 | 427 | 64 | -705 | 21 | 133 | -9 | -2 |
Depreciation and amortization | ||||||||
- | - | - | - | - | 390 | 425 | 500 | 491 |
Accretion of financing instruments and amortization of prepaid financing costs | ||||||||
58 | 105 | 105 | 192 | 239 | 237 | - | - | - |
Stock based compensation | ||||||||
144 | 14 | 49 | 31 | 104 | - | - | - | - |
Impairment of intangible assets | ||||||||
- | - | - | 404 | 0 | - | - | - | - |
Release of accounts payable no longer owed | ||||||||
- | - | - | 406 | 0 | - | - | - | - |
Change in deferred tax assets | ||||||||
33 | 256 | -823 | 0 | - | - | - | - | - |
Unrealized (gain) loss on investments | ||||||||
-23 | - | - | - | - | - | - | - | - |
Impairment charge on investment in iBio, Inc. | ||||||||
- | 358 | 36 | 0 | - | - | - | - | - |
Non cash loss (gain) on AgroSport LLC investment | ||||||||
-97 | 88 | 0 | - | - | - | - | - | - |
Allowance for doubtful accounts | ||||||||
-50 | 42 | -1 | 30 | -20 | -7 | -13 | -3 | -45 |
Non cash charge of professional fees incurred in connection with Convertible Note Payable - CD Financial, LLC | ||||||||
- | - | - | - | - | - | - | 53 | 197 |
Gain on disposal of fixed assets | ||||||||
- | 5 | 0 | 15 | 3 | 4 | -6 | -1 | -31 |
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ||||||||
593 | -182 | 884 | 527 | 440 | -248 | - | - | - |
Accounts receivable | ||||||||
- | - | - | - | - | - | 371 | 627 | 269 |
Inventories | ||||||||
1,077 | 96 | -111 | 1,978 | 79 | -733 | 1,140 | -2,106 | -408 |
Other current assets | ||||||||
73 | 7 | 43 | 99 | 42 | -36 | -81 | 641 | 52 |
Accounts payable | ||||||||
-329 | 7 | -1,292 | 727 | -488 | -247 | -598 | -352 | 1,106 |
Accrued expenses and other liabilities | ||||||||
96 | -133 | -27 | -326 | 229 | 187 | -428 | - | - |
Operating lease obligations | ||||||||
-454 | - | - | - | - | - | - | - | - |
Net cash provided by (used in) operating activities | ||||||||
- | - | - | -594 | -113 | - | - | - | - |
Accrued expenses and other current liabilities | ||||||||
- | - | - | - | - | - | - | 891 | -116 |
Net cash provided by (used in) operating activities | ||||||||
328 | 1,168 | 397 | - | - | 1,877 | -1,438 | -771 | 392 |
Cash flows from investing activities: | ||||||||
Purchase of property and equipment | ||||||||
414 | 247 | 327 | 109 | 235 | 182 | 30 | 155 | 301 |
Proceeds from sale of machinery and equipment | ||||||||
- | 6 | 0 | 2 | 0 | - | 19 | - | - |
Cash contribution in AgroSport LLC | ||||||||
8 | 1 | 0 | - | - | - | - | - | - |
Net cash used in investing activities | ||||||||
- | - | - | -107 | - | - | - | - | - |
Proceeds from common stock sales of iBio, Inc. | ||||||||
- | - | - | - | 79 | 0 | - | - | - |
Proceeds from sale of property and equipment | ||||||||
- | - | - | - | - | - | - | 12 | 32 |
Net cash used in investing activities | ||||||||
-422 | -242 | -327 | - | -156 | -182 | -11 | -143 | -269 |
Cash flows from financing activities: | ||||||||
Advances under revolving credit facility | ||||||||
48,937 | 41,164 | 45,385 | 41,166 | 36,993 | 32,341 | 34,714 | 2,679 | - |
Proceeds from issuance of note payable | ||||||||
2,400 | - | - | 1,975 | 0 | - | - | 3,768 | 40 |
Proceeds from sales/lease back of equipment | ||||||||
233 | 143 | 158 | 0 | - | - | - | - | - |
Proceeds from exercise of employee stock options | ||||||||
24 | - | 3 | 0 | - | 4 | - | - | - |
Repayments of advances under revolving credit facility | ||||||||
47,997 | 40,945 | 44,919 | 41,418 | 36,652 | 32,763 | 32,848 | 2 | - |
Proceeds from Line of Credit Note | ||||||||
- | - | - | 43 | 307 | 0 | - | - | - |
Repayments under term note payables | ||||||||
3,023 | 959 | 829 | 620 | 616 | 834 | 496 | 7,805 | -40 |
Repayments under finance lease obligations | ||||||||
233 | 233 | 131 | 121 | 143 | 47 | 11 | 20 | 45 |
Net cash (used in) provided by financing activities | ||||||||
- | - | - | 1,025 | - | - | - | - | - |
Net cash (used in) provided by financing activities | ||||||||
341 | -830 | -333 | - | -111 | -1,299 | 1,359 | 334 | -45 |
Net increase in cash | ||||||||
247 | 96 | -263 | 324 | -380 | 396 | -90 | -580 | 78 |
Supplemental disclosures of cash flow information: | ||||||||
Interest paid | ||||||||
629 | 800 | 884 | - | - | - | - | - | - |
Interest | ||||||||
- | - | - | 745 | 714 | 716 | 671 | - | - |
Income taxes paid | ||||||||
264 | 221 | 366 | 168 | 158 | 7 | 17 | - | - |
Accretion of discount on Convertible Note Payable | ||||||||
3 | 39 | 39 | 86 | 110 | 108 | - | - | - |
Accretion on embedded derivative feature of Convertible Note Payable | ||||||||
- | - | - | - | - | - | 106 | - | - |
Financing on capitalized lease obligations | ||||||||
- | 53 | 0 | 317 | 185 | 72 | 68 | - | - |